In a rare disease medication push, Merck will buy Acceleron for around $11.5 billion.

WORLD NEWS

In a rare disease medication push, Merck will buy Acceleron for around $11.5 billion.

September 30, 2021September 30, 2021

Merck & Co will pay around $11.5 billion for drugmaker Acceleron Pharma Inc, the companies announced on Thursday, as the American pharmaceutical giant tries to expand its portfolio with treatments for rare disorders.

20.00k

60.00k

100.00k

500.00k

600.00k